Research of Primary Lateral Sclerosis has been linked to Sclerosis, Amyotrophic Lateral Sclerosis, Neurodegenerative Disorders, Motor Neuron Disease, Nerve Degeneration. The study of Primary Lateral Sclerosis has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Primary Lateral Sclerosis include Pathogenesis, Cell Death, Transport, Neuron Death, Localization. These pathways complement our catalog of research reagents for the study of Primary Lateral Sclerosis including antibodies and ELISA kits against SOD1, IGFALS, TARDBP, MOTOR NEURON DEGENERATION, FUS.
Primary Lateral Sclerosis Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Primary Lateral Sclerosis below!
For more information on how to use Laverne, please read the How to Guide.
We have 2161 products for the study of Primary Lateral Sclerosis that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Primary Lateral Sclerosis is also known as Lateral Scleroses, Lateral Sclerosis, Lateral Sclerosis, Primary, Sclerosis, Lateral, Sclerosis, Primary Lateral.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.